Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 10.37% is 100% above its 5-year average of 5.17%, near the high end of its 5-year range (2.31%–10.72%).
As of the fiscal period ended Tuesday, June 30, 2026. 0.79% below its 12-month average of 10.45%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 10.37%.
DEBT TO ASSETS RATIO
10.37%
DEBT TO ASSETS RATIO AVG TTM
10.45%
DEBT TO ASSETS RATIO AVG 3Y
7.18%
DEBT TO ASSETS RATIO AVG 5Y
5.17%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-0.79%
CURRENT VS 3Y AVG
+44.38%
CURRENT VS 5Y AVG
+100.48%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 580 covered companies
CURRENT VS SECTOR MEDIAN
+10271.64%
vs the sector median at left
AbCellera Biologics Inc.
Market Cap
$4.04B
Debt to Assets Ratio
10.37%
TTM Avg
10.45%
3Y Avg
7.18%
5Y Avg
5.17%
Market Cap
$4.30B
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.33B
Debt to Assets Ratio
0.08%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.41B
Debt to Assets Ratio
0.41%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.43B
Debt to Assets Ratio
0.64%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.58B
Debt to Assets Ratio
0.67%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.50B
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AbCellera Biologics Inc. (ABCL) | $4.04B | 10.37% | 10.45% | 7.18% | 5.17% |
| ICU Medical, Inc. (ICUI)vs › | $3.97B | 0.32% | N/A | N/A | N/A |
| LivaNova PLC (LIVN)vs › | $4.16B | 0.13% | N/A | N/A | N/A |
| Edgewise Therapeutics, Inc. (EWTX)vs › | $4.30B | 0.01% | N/A | N/A | N/A |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.33B | 0.08% | N/A | N/A | N/A |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.41B | 0.41% | N/A | N/A | N/A |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.43B | 0.64% | N/A | N/A | N/A |
| iRhythm Technologies, Inc. (IRTC)vs › | $3.58B | 0.67% | N/A | N/A | N/A |
| IDEAYA Biosciences, Inc. (IDYA)vs › | $3.50B | 0.02% | N/A | N/A | N/A |
| CareDx, Inc (CDNA)vs › | $3.47B | 0.04% | N/A | N/A | N/A |
Debt/Assets
10.4%
Debt/Equity
0.15
Current Ratio
12.77
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 10.37% |
| 2026-03-31 | 10.72% |
| 2025-12-31 | 10.55% |
| 2025-09-30 | 10.49% |
| 2025-06-30 | 10.13% |
| 2025-03-31 | 5.05% |
| 2024-12-31 | 4.80% |
| 2024-09-30 | 5.13% |
| 2024-06-30 | 5.10% |
| 2024-03-31 | 5.03% |
| 2023-12-31 | 5.20% |
| 2023-09-30 | 5.34% |
| 2023-06-30 | 5.47% |
| 2023-03-31 | 5.55% |
| 2022-12-31 | 5.34% |
| 2022-09-30 | 4.90% |
| 2022-06-30 | 2.31% |
| 2022-03-31 | 2.53% |
| 2021-12-31 | 3.04% |
| 2021-09-30 | 2.56% |
| 2021-06-30 | 2.89% |
| 2021-03-31 | 1.64% |
| 2020-12-31 | 0.67% |
| 2020-09-30 | 4.15% |
| 2020-06-30 | 12.99% |
| 2019-12-31 | 29.34% |
